L'Oreal 2Q sales rise but depressed China market weighs
Adds details on business units in paragraphs 10-13, analyst comment, share moves at peers
By Dominique Patton
PARIS, July 30 (Reuters) -French cosmetics giant L'Oreal OREP.PA reported a 5.3% rise in second-quarter sales, below expectations and likely further rattling investors already worried about the lack of rebound in the important Chinese market.
The Paris-based company, which owns the Maybelline and Lancome brands, said on Tuesday that sales in the quarter reached 10.88 billion euros ($11.75 billion), up 5.3% on a like-for-like basis from a year earlier, but undershooting the 5.9% growth seen in a consensus compiled by Visible Alpha.
The growth, the slowest for a quarter since at least the start of 2022, comes as the global beauty market adjusts to a less dynamic pace of sales after a pent-up surge following the pandemic.
Luxury bellwether LVMH LVMH.PA last week said its perfumes and cosmetics sales grew 4% in the second quarter, slowing from 7% in the first three months of the year.
Shares in U.S. rival Estee Lauder EL.N were down 2.7% after L'Oreal published its sales, while beauty firm Coty COTY.N fell 3%.
L'Oreal CEO Nicolas Hieronimus had said last month that the global beauty market was growing more slowly than earlier predicted, at about 4.5%-5%, largely due to a lack of rebound in the Chinese market.
Shoppers in China, which has been one of the world's fastest growing beauty markets, are cutting back on spending over worries about job insecurity and a prolonged real estate slump.
The world's No. 2 economy grew less than expected in the second quarter, prompting consumers to buy fewer creams and lipsticks, both online and in stores.
L'Oreal, whose products span the mass market to the high-end luxury segment, had been expected to outpace its peers, but still posted a 2.4% decline in like-for-like sales in North Asia, which come mostly from mainland China. That followed a 1.1% drop in the first quarter.
"In mainland China, the beauty market was negative in the second quarter on a tough comparison base, exacerbated by lasting low consumer confidence," said the company in a statement.
Growth also slowed sharply in North America to 3.4% for the quarter, but Europe sales rose by 9.7%.
"Europe continues to defy gravity," said analysts at Jefferies.
The company also highlighted the strong performance in its luxury division that markets YSL Libre perfume and Prada makeup. The business grew 2.8%, beating expectations for a 1.6% rise, thanks to "robust" growth in Europe and "double-digit" growth in North America and emerging markets.
In the consumer products division, which includes its L'Oreal Paris mascaras and Garnier skincare and accounts for more than a third of its revenue, sales grew 6.7% on a like-for-like basis.
The smaller but fast-growing dermatological beauty unit, which sells La Roche-Posay and CeraVe skincare, grew 10.8%, at a much less rapid pace from prior quarters, due to slower demand in the U.S.
Shares in L'Oreal, Europe's 6th most valuable listed company, with a market capitalisation of about 211 billion euros, have lost 12% so far this year, compared to a 31% fall at U.S. peer Estee Lauder EL.N.
($1 = 0.9257 euros)
Reporting by Dominique Patton; editing by David Evans
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
